Blood online
Home About Blood Authors Subscriptions Permission Advertising Public Access contact us
 

 
Advanced
Current Issue
First Edition
Future Articles
Archives
Submit to Blood
Search
American Society of Hematology
Meeting Abstracts
Email Alerts
Blood, 1 July 2005, Vol. 106, No. 1, pp. 43-50.
Prepublished online as a Blood First Edition Paper on March 1, 2005; DOI 10.1182/blood-2004-10-4144.


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
2004-10-4144v1
106/1/43    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Right arrow Rights and Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Röth, A.
Right arrow Articles by Lansdorp, P. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Röth, A.
Right arrow Articles by Lansdorp, P. M.
Related Collections
Right arrow Immunobiology
Right arrow Gene Therapy
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

arrow to previous article Previous Article  |  Table of Contents  |  Next Article next article arrow

GENE THERAPY

Telomere loss, senescence, and genetic instability in CD4+ T lymphocytes overexpressing hTERT

Alexander Röth, Gabriela M. Baerlocher, Mike Schertzer, Elizabeth Chavez, Ulrich Dührsen, and Peter M. Lansdorp

From the Terry Fox Laboratory, British Columbia Cancer Agency, Vancouver, BC, Canada; Department of Hematology, University Hospital, Essen, Germany; Department of Hematology, University Hospital, Bern, Switzerland; and Department of Medicine, University of British Columbia, Vancouver, BC, Canada.

Little is known about the long-term consequences of overexpression of the human telomerase reverse transcriptase (hTERT) gene in T lymphocytes. To address this issue, we transduced polyclonal as well as clonally derived populations of naive and memory CD4+ T cells from 2 healthy donors (aged 24 and 34 years) with retroviral vectors encoding green fluorescence protein (GFP) and hTERT (GFP-hTERT) or GFP alone. After transduction, cells were sorted on the basis of GFP expression and cultured in vitro until senescence. T cells transduced with hTERT exhibited high stable telomerase activity throughout the culture period. Relative to GFP controls, minor changes in overall gene expression were observed yet the proliferative lifespan of the hTERT-transduced populations was significantly increased and the rate of telomere loss was lower. Nevertheless, hTERT-transduced cells showed progressive telomere loss and had shorter telomeres at senescence than controls (2.3 ± 0.3 kilobase [kb] versus 3.4 ± 0.1 kb). Furthermore, a population of cells with 4N DNA consisting of binucleated cells with connected nuclei emerged in the hTERT-transduced cells prior to senescence. We conclude that overexpression of hTERT in CD4+ T cells provides a proliferative advantage independent of the average telomere length but does not prevent eventual genetic instability and replicative senescence.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
Proc. Natl. Acad. Sci. USAHome page
H. Fujii, L. Shao, I. Colmegna, J. J. Goronzy, and C. M. Weyand
Telomerase insufficiency in rheumatoid arthritis
PNAS, March 17, 2009; 106(11): 4360 - 4365.
[Abstract] [Full Text] [PDF]


Home page
Physiol. Rev.Home page
G. Aubert and P. M. Lansdorp
Telomeres and Aging
Physiol Rev, April 1, 2008; 88(2): 557 - 579.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
A. N. Akbar and M. Vukmanovic-Stejic
Telomerase in T Lymphocytes: Use It and Lose It?
J. Immunol., June 1, 2007; 178(11): 6689 - 6694.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
O. Menzel, M. Migliaccio, D. R. Goldstein, S. Dahoun, M. Delorenzi, and N. Rufer
Mechanisms Regulating the Proliferative Potential of Human CD8+ T Lymphocytes Overexpressing Telomerase
J. Immunol., September 15, 2006; 177(6): 3657 - 3668.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
M. W. J. Schreurs, M. A. J. A. Hermsen, R. I. K. Geltink, K. B. J. Scholten, A. A. T. P. Brink, E. W. M. Kueter, M. Tijssen, C. J. L. M. Meijer, B. Ylstra, G. A. Meijer, et al.
Genomic stability and functional activity may be lost in telomerase-transduced human CD8+ T lymphocytes
Blood, October 15, 2005; 106(8): 2663 - 2670.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
J. C. Y. Wang, J. K. Warner, N. Erdmann, P. M. Lansdorp, L. Harrington, and J. E. Dick
Dissociation of telomerase activity and telomere length maintenance in primitive human hematopoietic cells
PNAS, October 4, 2005; 102(40): 14398 - 14403.
[Abstract] [Full Text] [PDF]



 click for free articles
home about blood authors subscriptions permissions advertising public access contact us
  Copyright © 2005 by American Society of Hematology         Online ISSN: 1528-0020